Mediwelcome Healthcare Management & Technology Inc
HKEX:2159
Mediwelcome Healthcare Management & Technology Inc
HKEX:2159
Price:
1.48
HKD
Market Closed
Market Cap:
HK$414.4m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Mediwelcome Healthcare Management & Technology Inc
HKEX:2159
|
CN |
|
F
|
First Industrial Realty Trust Inc
BMV:FR
|
US |
|
IST:KZGYO.E
|
TR | |
|
T
|
Tracker Corporation of America
OTC:TRKR
|
CA |
|
O
|
Otto Energy Ltd
SWB:O1E
|
AU |
|
Industrivarden AB
STO:INDU A
|
SE |
|
National Bank of Canada
TSX:NA
|
CA |
|
C
|
Compagnie d'entreprises CFE SA
LSE:0O2T
|
BE |
|
Zenta Group Co Ltd
NASDAQ:ZTG
|
MO |
|
Verastem Inc
LSE:0LOV
|
US |
|
M
|
Mckesson Corp
LSE:0JZU
|
US |
|
Hexpol AB
LSE:0R7O
|
SE |
Income Statement
Earnings Waterfall
Mediwelcome Healthcare Management & Technology Inc
Mediwelcome Healthcare Management & Technology Inc
Income Statement
Mediwelcome Healthcare Management & Technology Inc
Mediwelcome Healthcare Management & Technology Inc
Currency: CNY
| Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||
| Interest Expense |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
|
| Revenue |
708
N/A
|
541
-24%
|
323
-40%
|
298
-8%
|
331
+11%
|
325
-2%
|
322
-1%
|
308
-4%
|
468
+52%
|
|
| Gross Profit | ||||||||||
| Cost of Revenue |
(615)
|
(466)
|
(291)
|
(264)
|
(301)
|
(293)
|
(271)
|
(256)
|
(373)
|
|
| Gross Profit |
94
N/A
|
75
-20%
|
33
-57%
|
34
+5%
|
30
-12%
|
32
+6%
|
51
+61%
|
52
+2%
|
95
+82%
|
|
| Operating Income | ||||||||||
| Operating Expenses |
(87)
|
(112)
|
(124)
|
(117)
|
(104)
|
(110)
|
(77)
|
(73)
|
(93)
|
|
| Selling, General & Administrative |
(76)
|
(76)
|
(72)
|
(76)
|
(71)
|
(68)
|
(59)
|
(51)
|
(64)
|
|
| R&D |
(19)
|
(38)
|
(51)
|
(44)
|
(33)
|
(25)
|
(19)
|
(13)
|
(28)
|
|
| Depreciation & Amortization |
0
|
0
|
(3)
|
0
|
(3)
|
0
|
(2)
|
0
|
0
|
|
| Other Operating Expenses |
8
|
2
|
3
|
3
|
2
|
(18)
|
2
|
(9)
|
(1)
|
|
| Operating Income |
7
N/A
|
(37)
N/A
|
(91)
-146%
|
(83)
+9%
|
(74)
+11%
|
(79)
-7%
|
(26)
+67%
|
(21)
+21%
|
2
N/A
|
|
| Pre-Tax Income | ||||||||||
| Interest Income Expense |
(0)
|
1
|
3
|
3
|
2
|
1
|
0
|
(1)
|
(1)
|
|
| Non-Recurring Items |
(9)
|
2
|
0
|
0
|
(19)
|
0
|
(12)
|
0
|
8
|
|
| Total Other Income |
8
|
5
|
(3)
|
(1)
|
(6)
|
(3)
|
(8)
|
(6)
|
(1)
|
|
| Pre-Tax Income |
6
N/A
|
(29)
N/A
|
(91)
-218%
|
(80)
+12%
|
(96)
-20%
|
(81)
+16%
|
(45)
+44%
|
(27)
+40%
|
7
N/A
|
|
| Net Income | ||||||||||
| Tax Provision |
(0)
|
2
|
(3)
|
(3)
|
0
|
(0)
|
(2)
|
(1)
|
0
|
|
| Income from Continuing Operations |
5
|
(27)
|
(94)
|
(84)
|
(96)
|
(81)
|
(47)
|
(28)
|
7
|
|
| Income to Minority Interest |
(1)
|
1
|
5
|
5
|
2
|
0
|
2
|
(1)
|
3
|
|
| Net Income |
5
N/A
|
(26)
N/A
|
(89)
-246%
|
(79)
+12%
|
(94)
-20%
|
(81)
+14%
|
(45)
+44%
|
(29)
+36%
|
10
N/A
|
|
| EPS (Diluted) |
0.03
N/A
|
-0.14
N/A
|
-0.48
-243%
|
-0.42
+13%
|
-0.49
-17%
|
-0.42
+14%
|
-0.24
+43%
|
-0.15
+38%
|
0.04
N/A
|
|
Switch to:
Switch to:
See Also
Discover More
